FR11C0037I1 - - Google Patents
Info
- Publication number
- FR11C0037I1 FR11C0037I1 FR11C0037C FR11C0037I1 FR 11C0037 I1 FR11C0037 I1 FR 11C0037I1 FR 11C0037 C FR11C0037 C FR 11C0037C FR 11C0037 I1 FR11C0037 I1 FR 11C0037I1
- Authority
- FR
- France
- Prior art keywords
- derivatives
- peperidino
- mycaminosyltylonolide
- pasteurellosis
- disubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WGUJDBLMJBJUQU-VKRLOHBMSA-N 5-O-mycaminosyltylonolide Chemical class O=CC[C@H]1C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@H](CO)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O)[C@@H](C)O1 WGUJDBLMJBJUQU-VKRLOHBMSA-N 0.000 abstract 1
- 241000606860 Pasteurella Species 0.000 abstract 1
- 206010034107 Pasteurella infections Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 201000005115 pasteurellosis Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24328699 | 1999-08-30 | ||
| PCT/JP2000/005721 WO2001016148A1 (en) | 1999-08-30 | 2000-08-24 | Macrolide antibiotics and treatment of pasteurellosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR11C0037I1 true FR11C0037I1 (forum.php) | 2011-10-14 |
| FR11C0037I2 FR11C0037I2 (fr) | 2012-06-22 |
Family
ID=17101600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR11C0037C Active FR11C0037I2 (fr) | 1999-08-30 | 2011-09-09 | Antibiotiques macrolides et traitement de la pasteurellose |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6514946B1 (forum.php) |
| EP (1) | EP1216256B1 (forum.php) |
| JP (1) | JP4573411B2 (forum.php) |
| AT (1) | ATE261450T1 (forum.php) |
| AU (1) | AU763732B2 (forum.php) |
| BE (1) | BE2011C037I2 (forum.php) |
| CA (1) | CA2391834C (forum.php) |
| DE (2) | DE122011100013I1 (forum.php) |
| DK (1) | DK1216256T3 (forum.php) |
| ES (1) | ES2213597T3 (forum.php) |
| FR (1) | FR11C0037I2 (forum.php) |
| PT (1) | PT1216256E (forum.php) |
| WO (1) | WO2001016148A1 (forum.php) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006078032A1 (ja) * | 2005-01-24 | 2006-07-27 | Microbial Chemistry Research Foundation | 抗ペニシリン耐性肺炎球菌剤及び新規１６員環マクロライド誘導体 |
| US9148795B2 (en) * | 2005-12-22 | 2015-09-29 | Qualcomm Incorporated | Methods and apparatus for flexible reporting of control information |
| CN101506220B (zh) * | 2006-07-28 | 2012-10-17 | 英特威国际有限公司 | 大环内酯合成方法 |
| ES2374950T3 (es) * | 2006-07-28 | 2012-02-23 | Intervet International B.V. | Procedimiento de síntesis de macrolidos. |
| KR101538599B1 (ko) * | 2006-07-28 | 2015-07-21 | 인터벳 인터내셔널 비.브이. | 마크롤라이드 합성 방법 |
| EP2019112A1 (en) * | 2007-07-26 | 2009-01-28 | Intervet International BV | Macrolide solid-state forms |
| CN102863487B (zh) * | 2012-10-08 | 2014-11-05 | 齐鲁动物保健品有限公司 | 20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的制备方法 |
| TR201809189T4 (tr) * | 2013-05-23 | 2018-07-23 | Bayer Animal Health Gmbh | Tylosin türevleri̇ ve bunlarin hazirlanmasina yöneli̇k yöntem. |
| CN103554203A (zh) * | 2013-08-17 | 2014-02-05 | 齐鲁动物保健品有限公司 | 一种泰地罗新无定形晶及其制备方法 |
| CN104788519B (zh) * | 2014-01-22 | 2018-07-20 | 镇江威特药业有限责任公司 | 十六元环三胺内酯衍生物及其应用 |
| CN103923141B (zh) * | 2014-04-21 | 2016-04-27 | 西南大学 | 一种依托替米考星的合成方法 |
| CN104478974B (zh) * | 2014-11-28 | 2016-08-17 | 武汉回盛生物科技有限公司 | 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法 |
| CN104447919B (zh) * | 2014-11-28 | 2017-03-08 | 武汉回盛生物科技股份有限公司 | 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法 |
| CN104497082B (zh) * | 2015-01-13 | 2017-12-12 | 中国兽医药品监察所 | 一种泰地罗新的合成方法 |
| CN104558076A (zh) * | 2015-02-10 | 2015-04-29 | 上海皓元化学科技有限公司 | 一种泰地罗新的制备方法及其中间体化合物 |
| US10287275B2 (en) * | 2015-04-16 | 2019-05-14 | Victor Pharma Co., Ltd. Zhenjiang | 16-member triamilide derivatives and uses thereof |
| CN105440093A (zh) * | 2015-11-17 | 2016-03-30 | 宁夏泰瑞制药股份有限公司 | 一种泰地罗新的合成方法 |
| CN105919933A (zh) * | 2016-06-13 | 2016-09-07 | 上海同仁药业股份有限公司 | 泰地罗新注射液及其制备方法 |
| CN106420600A (zh) * | 2016-09-21 | 2017-02-22 | 中国水产科学研究院珠江水产研究所 | 一种替米考星注射用原位凝胶及其制备方法 |
| CN108264529A (zh) * | 2016-12-30 | 2018-07-10 | 湖北回盛生物科技有限公司 | 一种20,23-二哌啶-5-o-碳霉胺糖基-泰乐内酯的合成方法 |
| CN108264530A (zh) * | 2016-12-30 | 2018-07-10 | 湖北回盛生物科技有限公司 | 20,23-二卤代-5-o-碳霉胺糖基-泰乐内酯及其合成方法和应用 |
| US20240000820A1 (en) | 2020-12-03 | 2024-01-04 | Intervet Inc. | A method of treating foot rot |
| CN116731096B (zh) * | 2023-06-10 | 2025-03-04 | 中国兽医药品监察所 | 20-醛基-23-哌啶基-5-o-碳霉胺糖基-泰乐内酯及其合成方法及它的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454314A (en) | 1982-08-02 | 1984-06-12 | Pfizer Inc. | Antibacterial mycaminosyl tylonolide and related macrolide derivatives |
| JPS5951299A (ja) * | 1982-09-17 | 1984-03-24 | Microbial Chem Res Found | ２３−デオキシ−２０−ジヒドロ−マイカミノシルタイロノライド誘導体 |
| JPS59225199A (ja) * | 1983-02-10 | 1984-12-18 | Microbial Chem Res Found | ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換アミノマイカミノシルレロノライド |
| ZA841277B (en) * | 1983-02-28 | 1985-09-25 | Lilly Co Eli | C-20-and c-23-modified macrolide derivatives |
| US4629786A (en) | 1983-02-28 | 1986-12-16 | Eli Lilly And Company | C-20- and C-23 modified macrolide derivatives |
| IL71032A0 (en) * | 1983-02-28 | 1984-05-31 | Lilly Co Eli | C-20 and c-23-modified macrolide derivatives |
| JPS59181299A (ja) * | 1983-03-31 | 1984-10-15 | Microbial Chem Res Found | ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド |
| JPS59227897A (ja) * | 1983-06-10 | 1984-12-21 | Microbial Chem Res Found | ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換−マイカミノシルレロノライド |
| US4604380A (en) * | 1985-01-18 | 1986-08-05 | Eli Lilly And Company | C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use |
| TW226373B (forum.php) * | 1992-07-15 | 1994-07-11 | Pfizer |
-
2000
- 2000-08-24 EP EP00955002A patent/EP1216256B1/en not_active Expired - Lifetime
- 2000-08-24 PT PT00955002T patent/PT1216256E/pt unknown
- 2000-08-24 DE DE201112100013 patent/DE122011100013I1/de active Pending
- 2000-08-24 DE DE60008895T patent/DE60008895T2/de not_active Expired - Lifetime
- 2000-08-24 CA CA002391834A patent/CA2391834C/en not_active Expired - Lifetime
- 2000-08-24 AU AU67294/00A patent/AU763732B2/en not_active Expired
- 2000-08-24 DK DK00955002T patent/DK1216256T3/da active
- 2000-08-24 ES ES00955002T patent/ES2213597T3/es not_active Expired - Lifetime
- 2000-08-24 AT AT00955002T patent/ATE261450T1/de active
- 2000-08-24 WO PCT/JP2000/005721 patent/WO2001016148A1/en active IP Right Grant
- 2000-08-29 US US09/649,038 patent/US6514946B1/en not_active Expired - Lifetime
- 2000-08-29 JP JP2000258699A patent/JP4573411B2/ja not_active Expired - Lifetime
-
2011
- 2011-09-09 FR FR11C0037C patent/FR11C0037I2/fr active Active
- 2011-10-26 BE BE2011C037C patent/BE2011C037I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2213597T3 (es) | 2004-09-01 |
| CA2391834C (en) | 2008-08-05 |
| AU6729400A (en) | 2001-03-26 |
| DE60008895T2 (de) | 2005-01-20 |
| EP1216256B1 (en) | 2004-03-10 |
| ATE261450T1 (de) | 2004-03-15 |
| DE122011100013I1 (de) | 2011-09-15 |
| FR11C0037I2 (fr) | 2012-06-22 |
| BE2011C037I2 (forum.php) | 2019-10-16 |
| CA2391834A1 (en) | 2001-03-08 |
| JP4573411B2 (ja) | 2010-11-04 |
| US6514946B1 (en) | 2003-02-04 |
| PT1216256E (pt) | 2004-07-30 |
| AU763732B2 (en) | 2003-07-31 |
| WO2001016148A1 (en) | 2001-03-08 |
| DE60008895D1 (de) | 2004-04-15 |
| EP1216256A1 (en) | 2002-06-26 |
| JP2001139592A (ja) | 2001-05-22 |
| DK1216256T3 (da) | 2004-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2011C037I2 (forum.php) | ||
| AU6339599A (en) | Quinoline derivatives and their use as antibacterial agents | |
| ZA981132B (en) | Methods, compositions and articles for reducing or preventing the effects of inflammation. | |
| GEP19991538B (en) | Derivatives of Erytromycin and Pharmaceutical Composition on their Basis | |
| MXPA02001508A (es) | Derivados de arilmetil-carbonilamino-tiazol y sus usos como agentes antitumorales. | |
| FI954979A7 (fi) | Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset | |
| MXPA03000708A (es) | Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana. | |
| FI951538A7 (fi) | Parannettu fysikaaliset ominaisuudet omaavat koostumukset, esineet ja menetelmät hapen poistamiseksi | |
| ZA973105B (en) | Compounds and methods for the selective treatment of cancer and bacterial infections. | |
| BG64475B1 (bg) | Ципразидонови соли | |
| FI950623A7 (fi) | Tyydyttymättömät hiilihydraattijohdannaiset, niistä saadut polymeerit ja näiden käyttö | |
| NZ507350A (en) | Semi-synthetic ecteinascidins and use in treatment of tumors | |
| GB9902555D0 (en) | Medicament | |
| PT946175E (pt) | Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais | |
| HUT75949A (en) | 13-substituted milbemycin derivatives, their use as herbicids and herbicid compositions | |
| DE69635224D1 (de) | 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität | |
| DE69108020D1 (de) | Polymerzusammensetzung, und daraus hergestellte Formkörper. | |
| PT1052991E (pt) | Utilizacao de loperamida para o tratamento de infeccoes microbianas | |
| AU6091299A (en) | Treatment device, treatment bed to be used therein and the use thereof | |
| ATE97909T1 (de) | Antibiotikum n-acetylbenanomicin b, dessen herstellung und verwendung. | |
| AU4506499A (en) | Novel 2,4-diaminophenol derivatives and the use thereof | |
| AU3061199A (en) | Skin treatment compositions and the use thereof | |
| MX9804068A (es) | Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos. | |
| EE200200267A (et) | Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiinid ja nende kasutamine ravimina | |
| FI955680L (fi) | Psoraleenijohdannaiset, niiden valmistus ja käyttö |